| Meet the Staff
Lisa Wood, PhD Title:
Assistant Professor, School of Nursing, Cancer Institute
Publications:
1. 'The Oncogenic properties of the HMGI gene family'. Wood LJ, Maher JF, Bunton TE, Resar LM. Cancer Research 2000, 60:4256-61.
2. 'HMG-I/Y, a new c-Myc target gene and potential oncogene'. Wood LJ, Mukherjee M, Dolde CE, Xu Y, Maher JF, Bunton TE, Williams JB, Resar LM. Mol. Cell Biol. 2000;20:5490-502.
3. 'C-CBL is not required for leukemia induction by Bcr-Abl in mice'. Dinulescu D, Wood LJ, Loriaux M, Shen L, Corless CL, Jauron-Mills L, Gross AL, Ren R, Deininger MW, Druker BJ. Oncogene 2003; 22:8852-60.
4. 'Transgenic mice overexpressing HMG-I in lymphoid tissue develop lymphoid hyperplasia and malignancy'. Xu Y, Bhattacharya R, Tesfaye A, Felder T, Wood LJ, Huso D, Resar, LMS. Cancer Research; 2004, 64: 3371-3375.
5. 'Cancer Chemotherapy Related Symptoms: Evidence to Suggest a Role for the Pro-Inflammatory Cytokines IL-1b, TNF-a and IL-6'. Oncology Nurs. Wood LJ, Nail LM, Fischer A, Winters K, Elsea CR. Forum, 2006, 33:535-42.
6. 'The cancer chemotherapy drug etoposide (VP-16) induces pro-inflammatory cytokine production and sickness behavior-like symptoms in a mouse model of cancer chemotherapy related symptoms'. Wood LJ, Nail LM, Elsea CR, Fischer A, Perrin NA, & Druker BJ. Biol. Res. Nursing, 2006-2007.
7. 'Kinase domain mutants of BCR-ABL: altered transformation potency irrespective of sensitivity to imatinib'. Griswold IJ, Bumm T, O’Hare T, Corbin AS, Stoffregen E, Moseson E, Wood LJ, Druker BJ and Deininger MW. Molecular & Cellular Biology 2006, 26:6082-93.
8. 'Characterization of murine JAK2V617F-positive myeloproliferative disease. Cancer Research'. Bumm T, Elsea C, Corbin AS, Loriaux M, Sherbenou D, Wood LJ, Deininger J, Silver RT, Druker BJ and Deininger MW. (In Press: December, 2006).
<< Back
|
|
;){kind=link}